Your browser doesn't support javascript.
loading
Influence of Aspirin on Plasma Levels of Lysophosphatidic Acid in Patients with Ischemic Cerebrovascular Diseases / 国际脑血管病杂志
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-402108
Biblioteca responsable: WPRO
ABSTRACT
To observe whether plasma levels of lysophosphatidic acid (LPA) can be decreased in patients with cerebrovascular diseases after the treatment with aspirin.

Methods:

A total of 1,400 patients were recruited. Among them,803 patients were diagnosed as probable ischemic stroke,and 343 patients were diagnosed as ischemic stroke. Thirty-four health volunteers were used as control subjects. The levels of LPA were measured by chromatography with the combination of inorganic phosphorus quantitative method.

Results:

The levels of LPA in the ischemic cerebrovascular group (3.11 ± 1.55 μmol/L) were significantly higher than those in the control group (1.77 ± 1.04 μmol/L) (P < 0.001). Taking aspirin (80 mg,qd) for one month significantly decreased the levels of LPA. After stopping aspirin for one month,the level of LPA re-elevated (3.90 ± 1.09 μmol/L),was higher than that during administration of aspirin (1.93 ±0.85 μmol/L(P <0.001).

Conclusions:

There are close correlations between the increased levels of LPA and the platelet activation. Aspirin decreases the level of plasma LPA;this may be one of the mechanisms of aspirin in prevention against ischemic stroke.

Texto completo: Disponible Base de datos: WPRIM (Pacífico Occidental) Idioma: Chino Revista: International Journal of Cerebrovascular Diseases Año: 2005 Tipo del documento: Artículo
Texto completo: Disponible Base de datos: WPRIM (Pacífico Occidental) Idioma: Chino Revista: International Journal of Cerebrovascular Diseases Año: 2005 Tipo del documento: Artículo
...